**Question:** All of the following diseases are due to excessive number of glutamine residues in proteins, EXCEPT

A. Polyglutamine disease (e.g., Huntington's disease)
B. Huntington's disease
C. Spinocerebellar ataxias (e.g., SCA1, SCA2, SCA3)
D. Amyotrophic lateral sclerosis (ALS)

**Core Concept:** Glutamine residues are amino acids that play a crucial role in protein structure and function. In certain diseases, the accumulation of abnormally long polyglutamine tracts can lead to protein misfolding and aggregation, which contributes to the pathogenesis of these diseases.

**Why the Correct Answer is Right:**
Option D, Amyotrophic lateral sclerosis (ALS), is a neurodegenerative disorder characterized by the progressive degeneration of motor neurons. Although ALS is a devastating disease, it is not directly associated with excessive glutamine residues in proteins. In contrast, the other options involve diseases caused by the expansion of CAG trinucleotide repeats, leading to the formation of toxic polyglutamine tracts.

**Why Each Wrong Option is Incorrect:**
Option A (Polyglutamine disease) involves diseases like Huntington's disease, which is caused by the expansion of CAG trinucleotide repeats and the subsequent formation of aggregated polyglutamine proteins.

Option B (Huntington's disease) is included in Option A, as it is also caused by the expansion of CAG trinucleotide repeats and polyglutamine protein aggregation.

Option C (Spinocerebellar ataxias) involves diseases like SCA1, SCA2, and SCA3, which are caused by the expansion of CAG trinucleotide repeats and the formation of toxic polyglutamine proteins.

**Clinical Pearl:** Understanding the role of polyglutamine proteins in these diseases is crucial for understanding the pathogenesis and potential therapeutic targets in neurodegenerative disorders.

**Core Concept:** Glutamine residues are essential for protein structure and function, but the accumulation of abnormally long polyglutamine tracts can lead to protein misfolding and aggregation, causing neurodegenerative diseases like Huntington's disease, Spinocerebellar ataxias, and certain prion diseases.

**Why Each Wrong Option is Incorrect:**
In the context of neurodegenerative diseases, polyglutamine aggregates lead to protein dysfunction and toxicity. Consequently, diseases like Huntington's disease, Spinocerebellar ataxias, and certain prion diseases are associated with polyglutamine protein aggregation.

**Why Option D is Incorrect:**
ALS is a different neurodegenerative disorder not directly related to polyglutamine protein aggregation. While ALS is also a motor neuron disease, it is not caused by polyglutamine protein aggregation. Instead, ALS is primarily associated with defects in various genes, leading to neurodegeneration.

**Clinical Pearl:** Understanding the differences between polyglutamine diseases and ALS is essential for differentiating between these disorders, as well as for recognizing therapeutic targets for each condition.